PLP (139-151) (trifluoroacetate salt) (Synonyms: linPLP, Proteolipid Peptide (139-151)) |
Catalog No.GC48331 |
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
PLP (139-151) is an encephalitogenic peptide fragment of myelin proteolipid protein (PLP).1 In vivo, PLP (139-151) (150 µg/animal) induces the formation of inflammatory foci, axonal injury, and demyelination in the spinal cord, as well as motor deficits in mice. It is commonly used to induce experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS), in mice.1,2,3
1.Lourbopoulos, A., Matsoukas, M.-T., Katsara, M., et al.Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitisBioorg. Med. Chem.26(9)2221-2228(2018) 2.Reddy, J., Bettelli, E., Nicholson, L., et al.Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramersJ. Immunol.170(2)870-877(2003) 3.Mohindru, M., Kang, B., and Kim, B.S.Functional maturation of proteolipid protein139-151-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitisJ. Neuroimmunol.155(1-2)127-135(2004)
Average Rating: 5
(Based on Reviews and 20 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *